MLN2201
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
MLN2201 is a humanized monoclonal antibody inhibitor that targets Integrinβ2. It can inhibit reperfusion injury following a stroke and is applicable for researching inflammatory conditions such as ischemic stroke.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRP-00130-01 100 mg
Recombinant humanized type III collagen (MW 55900)
Sign In for Pricing
View Details TRP-00130-02 250 mg
Recombinant humanized type III collagen (MW 55900)
Sign In for Pricing
View Details TRP-00130-03 50 mg
Recombinant humanized type III collagen (MW 55900)
Sign In for Pricing
View Details 